Increased muscle interstitial levels of inflammatory cytokines in polymyalgia rheumatica

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Increased muscle interstitial levels of inflammatory cytokines in polymyalgia rheumatica. / Kreiner, Frederik; Langberg, Henning; Galbo, Henrik.

In: Arthritis & Rheumatism, Vol. 62, No. 12, 2010, p. 3768-75.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kreiner, F, Langberg, H & Galbo, H 2010, 'Increased muscle interstitial levels of inflammatory cytokines in polymyalgia rheumatica', Arthritis & Rheumatism, vol. 62, no. 12, pp. 3768-75. https://doi.org/10.1002/art.27728

APA

Kreiner, F., Langberg, H., & Galbo, H. (2010). Increased muscle interstitial levels of inflammatory cytokines in polymyalgia rheumatica. Arthritis & Rheumatism, 62(12), 3768-75. https://doi.org/10.1002/art.27728

Vancouver

Kreiner F, Langberg H, Galbo H. Increased muscle interstitial levels of inflammatory cytokines in polymyalgia rheumatica. Arthritis & Rheumatism. 2010;62(12):3768-75. https://doi.org/10.1002/art.27728

Author

Kreiner, Frederik ; Langberg, Henning ; Galbo, Henrik. / Increased muscle interstitial levels of inflammatory cytokines in polymyalgia rheumatica. In: Arthritis & Rheumatism. 2010 ; Vol. 62, No. 12. pp. 3768-75.

Bibtex

@article{5ddfb93fbd25445fbf316dfec7dac3e7,
title = "Increased muscle interstitial levels of inflammatory cytokines in polymyalgia rheumatica",
abstract = "Polymyalgia rheumatica (PMR) is characterized by aching of the proximal muscles and increased blood levels of markers of inflammation. Despite the muscle complaints, the current view is that symptoms are caused by inflammation in synovial structures. The purpose of this study was to elucidate the disease mechanisms in symptomatic muscles by measuring interstitial levels of cytokines before and after prednisolone treatment.",
keywords = "Aged, Aged, 80 and over, C-Reactive Protein, Chemokine CCL2, Cytokines, Female, Glucocorticoids, Humans, Interleukin-1alpha, Interleukin-1beta, Interleukin-6, Interleukin-8, Male, Middle Aged, Muscle, Skeletal, Polymyalgia Rheumatica, Prednisolone, Tumor Necrosis Factor-alpha",
author = "Frederik Kreiner and Henning Langberg and Henrik Galbo",
note = "Copyright {\circledC} 2010 by the American College of Rheumatology.",
year = "2010",
doi = "10.1002/art.27728",
language = "English",
volume = "62",
pages = "3768--75",
journal = "Arthritis & Rheumatology",
issn = "2326-5205",
publisher = "Wiley",
number = "12",

}

RIS

TY - JOUR

T1 - Increased muscle interstitial levels of inflammatory cytokines in polymyalgia rheumatica

AU - Kreiner, Frederik

AU - Langberg, Henning

AU - Galbo, Henrik

N1 - Copyright © 2010 by the American College of Rheumatology.

PY - 2010

Y1 - 2010

N2 - Polymyalgia rheumatica (PMR) is characterized by aching of the proximal muscles and increased blood levels of markers of inflammation. Despite the muscle complaints, the current view is that symptoms are caused by inflammation in synovial structures. The purpose of this study was to elucidate the disease mechanisms in symptomatic muscles by measuring interstitial levels of cytokines before and after prednisolone treatment.

AB - Polymyalgia rheumatica (PMR) is characterized by aching of the proximal muscles and increased blood levels of markers of inflammation. Despite the muscle complaints, the current view is that symptoms are caused by inflammation in synovial structures. The purpose of this study was to elucidate the disease mechanisms in symptomatic muscles by measuring interstitial levels of cytokines before and after prednisolone treatment.

KW - Aged

KW - Aged, 80 and over

KW - C-Reactive Protein

KW - Chemokine CCL2

KW - Cytokines

KW - Female

KW - Glucocorticoids

KW - Humans

KW - Interleukin-1alpha

KW - Interleukin-1beta

KW - Interleukin-6

KW - Interleukin-8

KW - Male

KW - Middle Aged

KW - Muscle, Skeletal

KW - Polymyalgia Rheumatica

KW - Prednisolone

KW - Tumor Necrosis Factor-alpha

U2 - 10.1002/art.27728

DO - 10.1002/art.27728

M3 - Journal article

VL - 62

SP - 3768

EP - 3775

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

SN - 2326-5205

IS - 12

ER -

ID: 38363830